|
PF-30908 |
CONCILIUM 20 mg comprimidos |
2008-07-07 |
|
Panalab S.A. |
Guatemala
|
Panalab S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32251 |
ROFESIC 50 mg Comprimidos |
2009-03-04 |
|
Panalab S.A. |
Guatemala
|
Panalab S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32252 |
ROFESIC 25 mg Comprimidos |
2009-03-04 |
|
Panalab S.A. |
Guatemala
|
Panalab S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33878 |
TONVAL 40 mg Comprimidos con cubierta enterica |
2014-09-06 |
|
Panalab |
Guatemala
|
Leterago, S.A. |
Rodaco, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33879 |
TONVAL 20 mg Comprimidos con cubierta enterica |
2014-09-06 |
|
Panalab |
Guatemala
|
Leterago, S.A. |
Rodaco, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-15485 |
EMULSAN 20% emulsion inyectable |
2005-05-22 |
|
Laprin S.A. |
Guatemala
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-15486 |
EMULSAN 10% emulsion inyectable |
2005-05-22 |
|
Laprin S.A. |
Guatemala
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-43936 |
KABIVEN Emulsión para infusión (Central) |
2024-12-03 |
|
Fresenius Kabi Mexico, S.A. de C.V. |
Suecia
|
Xentury Global, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-43937 |
KABIVEN Periférico Emulsión para infusión |
2024-12-04 |
|
Fresenius Kabi Mexico, S.A. de C.V. |
Suecia
|
Xentury Global, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51177 |
BENZETACIL L-A 1,200,000 UI Polvo para suspension inyectable |
2020-03-23 |
|
Sandoz GmbH |
Italia
|
Farmalogsa |
Amicelco |
Novartis Farmacéutica, Sociedad Anónima (América Central) |
DASA |
Centro Distribuidor, Sociedad Anónima |
Norvanda Healthcare, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|